Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 367, Issue 3, 2003, Pages 297-305

  Felton, Tracy M ^a   Kang, Tommy B ^a   Hjorth, Stephan ^b   Auerbach, Sidney B ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

5 HT); Depression; Microdialysis; Mixed serotonin noradrenaline reuptake inhibitor (SNRI); Noradrenaline (norepinephrine); Selective serotonin reuptake inhibitor (SSRI); Serotonin (5 hydroxytryptamine

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ALPHA ADRENERGIC RECEPTOR; CHOLINERGIC RECEPTOR; CITALOPRAM; DULOXETINE; FLUOXETINE; HISTAMINE RECEPTOR; IMIPRAMINE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIENCEPHALON; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; EXTRACELLULAR SPACE; FRONTAL CORTEX; FRONTAL LOBE; MALE; METABOLISM; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; RAT; RAT STRAIN; SUBCUTANEOUS DRUG ADMINISTRATION; TIME;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; DIENCEPHALON; EXTRACELLULAR SPACE; FRONTAL LOBE; INJECTIONS, SUBCUTANEOUS; MALE; MICRODIALYSIS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0037354040     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-002-0688-x     Document Type: Article

References (44)

1. Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58:19-36
2. Auerbach SB, Lundberg JF, Horth S (1995) Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology 34:89-96
3. Baraban JM, Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355-363
4. Beique JC, de Montigny C, Blier P, Debonnel G (1998a) Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine. Br J Pharmacol 125:526-532
5. Beique JC, Lavoie N, de Montigny C, Debonnel G (1998b) Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol 349:129-132
6. Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245
7. Bel N, Artigas F (1996) In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function: microdialysis studies. J Pharmacol Exp Ther 278:1064-1072
8. Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW (2002) Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology 160:353-361
9. 1A receptor antagonism. Neuropharmacology 38:1153-1163
10. Delgado PL, Miller HL, Salomon RM, Licinio J, Krystal JH, Moreno FA, Heninger GR, Charney DS (1999) Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 46:212-220
11. De Montigny C, Silverstone PH, Debonnel G, Blier P, Bakish D (1999) Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial. J Clin Psychopharmacol 19:401-406
12. Engleman EA, Perry KW, Mayle DA, Wong DT (1995) Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor. Neuropsychopharmacology 12:287-295
13. Frazer A (1997) Pharmacology of antidepressants. J Clin Psychopharmacol 17 [Suppl 2]:2-18
14. Fuller RW (1994) Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 55:163-167
15. 1A autoreceptors in the mechanism of action of serotonergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 10:16-27
16. 1B receptors with WAY 100,635 and GR 127,935. J Neurochem 68:1159-1163
17. Gobert A, Rivet JM, Ciostarelli L, Melon C, Millan MJ (1997b) Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats. J Neurochem 69:2616-2619
18. Göthert M, Huth H, Schlicker E (1981) Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices. Naunyn-Schmiedebergs Arch Pharmacol 317:199-203
19. Gundlah C, Martin KF, Heal DJ, Auerbach SB (1997) In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor. J Pharmacol Exp Ther 283:581-591
20. Gur E, Dremencov E, Lerer B, Newman ME (1999) Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo. Eur J Pharmacol 372:17-24
21. Hervas I, Queiroz CM, Adell A, Artigas F (2000) Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. Br J Pharmacol 130:160-166
22. Heym J, Trulson ME, Jacobs BL (1981) Effects of adrenergic drugs on raphe unit activity in freely moving cats. Eur J Pharmacol 74:117-125
23. Hyttel (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacology 9 [Suppl 1]:19-26
24. Jacobs BL, Fornal CA (1991) Activity of brain serotonergic neurons in the behaving animal. Pharmacol Rev 43:563-578
25. Jordan S, Kramer GL, Zukas PK, Moeller M, Petty F (1994) In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse 18:294-297
26. Kihara T, Ikeda M (1995) Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. J Pharmacol Exp Ther 272:177-183
27. Kreiss DS, Lucki (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274:866-876
28. Millan MJ, Gobert A, Girardon S, Dekeyne A (1999) Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs. dopamine and noradrenaline. Eur J Pharmacol 364:147-150
29. Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet J M, Auclair A, Peglion JL (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters. I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther 298:565-580
30. Nierenberg A, Feigner JP, Rudolph R, Cole JO, Sullivan L (1994) Venlafaxine for treatment resistant unipolar depression. Arch Gen Psychiatry 48:419-423
31. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney
32. Perry PJ (1996) Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord 39:1-6
33. Portas CM, McCarley RW (1994) Behavioral state-related changes of extracellular serotonin concentration in the dorsal raphe nucleus: a microdialysis study in the freely moving cat. Br Res 648:306-312
34. Reith ME, Li MY, Yan QS (1997) Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology 134:309-317
35. 1A receptor function. Neuropharmacology 33:359-366
36. Rutter JJ, Auerbach SB (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J Pharmacol Exp Ther 265:1319-1324
37. Rutter JJ, Gundlah C, Auerbach SB (1994) Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 171:183-186
38. Sakai K, Crochet S (2000) Serotonergic dorsal raphe neurons cease firing by disfacilitation during paradoxical sleep. Neuroreport 11:3237-3241
39. Sánchez C, Hyttel J (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 19:467-489
40. 2-adrenoceptor modulation of 5-hydroxytryptamine release in rat ventral hippocampus in vivo. Naunyn-Schmiedebergs Arch Pharmacol 345:137-143
41. Wikell C, Bergqvist PB, Hjorth S, Apelqvist G, Bjork H, Bengtsson F (1998) Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy. Clin Neuropharm 21:296-396
42. Wilkinson LO, Auerbach SB, Jacobs BL (1991) Extracellular serotonin levels change with behavioral state but not with pyrogen-induced hyperthermia. J Neurosci 11:2732-2741
43. Wong DT, Bymaster FP (1976) The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain. Res Commun Chem Pathol Pharmacol 15:221-231
44. Wong DT, Bymaster FP, Mayle DA, Reid LR, Krushinski JH, Robertson DW (1993) LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology 8:23-33